AIM ImmunoTech Inc. Amended and Restated Certificate of Incorporation

AIM ImmunoTech Inc. filed a Form 8-K with the SEC on October 29, 2025, to report the amendment and restatement of its Certificate of Incorporation. The filing includes Exhibit 3.1(i), which contains the updated Certificate of Incorporation, superseding all previous versions. This document outlines the company's corporate structure and governance, reflecting any changes made to its foundational legal framework. The filing was signed by Thomas K. Equels, the CEO of AIM ImmunoTech Inc.